Cargando…
O002 A novel, optogenetics based therapy for obstructive sleep apnea
INTRODUCTION: Many obstructive sleep apnea (OSA) patients are sub-optimally treated due to poor tolerance or incomplete response to established therapies. We propose a novel stimulation therapy that sensitises the dilator muscles to light activation (‘optogenetics') and activates the muscles wi...
Autores principales: | Knapman, F, Cohen, M, Kulaga, T, Lisowski, L, Lovell, N, McMullan, S, Burke, P, Bilston, L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109414/ http://dx.doi.org/10.1093/sleepadvances/zpac029.001 |
Ejemplares similares
-
P063 Optogenetics for Obstructive Sleep Apnea
por: Knapman, F, et al.
Publicado: (2021) -
O054 Genioglossus neural drive and upper airway dilation in people with obstructive sleep apnoea during wakefulness
por: Jugé, L, et al.
Publicado: (2022) -
O027 Patterns of nocturnal swallow frequency and related tachycardia with sleep stages and obstructive sleep apnoea severity
por: Lin, A, et al.
Publicado: (2023) -
O013 The pathogenesis of obstructive sleep apnea in individuals with comorbid insomnia and obstructive sleep apnoea (COMISA)
por: Brooker, E, et al.
Publicado: (2021) -
O053 Obstructive sleep apnea is a distinct physiological phenotype in individuals with comorbid insomnia and sleep apnea (COMISA)
por: Brooker, E, et al.
Publicado: (2022)